ALX Oncology Holdings Inc. (ALXO) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of ALX Oncology Holdings Inc. and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TARA
Protara Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALXO vs TARA
growth of $100 · dividends reinvested · last 6yALXO -96.0% (-41.4%/yr)TARA -90.1% (-32.0%/yr)TARA compounded faster over this window
ALXO TARA
ALXO vs TARA: by the numbers
- •ALXO is the larger company ($149M vs $144M market cap).
Metrics side by side
Valuation
| Metric | ALXO | TARA |
|---|---|---|
| P/B ratio | 1.10 | 0.89 |
Profitability
| Metric | ALXO | TARA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -59.40% | -43.40% |
| ROIC | -56.53% | -47.18% |
Growth (annualized)
| Metric | ALXO | TARA |
|---|---|---|
| Total return CAGR (5Y) | -56.07% | -16.45% |
Frequently asked
- How have ALXO and TARA total returns compared?
- Over the past 5 years, ALXO delivered -56.07% and TARA delivered -16.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.